Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor glucose reprogramming suppresses cuproptosis: A review. | Biomol Biomed | 2025 | 40778735 | PubTator, text mining | PubMed |
| Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA-Methyltransferase 1 (DNMT1)/microRNA-302a-3p (miR-302a-3p)/ATPase Copper Transporting Beta (ATP7B) Axis. | MedComm (2020) | 2025 | 40761482 | PubTator, text mining | PubMed |
| Combined Analysis of Transcriptome and Mendelian Randomization Reveals AKT1 and PPARG as Biomarkers Related to Glucose Metabolism in Sepsis. | J Inflamm Res | 2025 | 40756416 | PubTator, text mining | PubMed |
| Copper ionophore enhanced cisplatin efficiency through DLAT-cuprotosis. | Toxicol Appl Pharmacol | 2025 | 40749953 | PubTator, text mining | PubMed |
| Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology. | Front Cell Dev Biol | 2025 | 40741332 | PubTator, text mining | PubMed |
| Triphenylphosphine-Chitosan Functionalized MoS2 Nanosheets Delivering Elesclomol-Cu(II) Complex for Enhanced Cuproptosis-Mediated Cancer Therapy. | Biomacromolecules | 2025 | 40740006 | PubTator, text mining | PubMed |
| Deciphering Cuproptosis in Sepsis: Mechanisms, Consequences, and Therapeutic Opportunities. | J Inflamm Res | 2025 | 40735271 | PubTator, text mining | PubMed |
| Bimetallic nanozyme-mediated dual ferroptosis/cuproptosis synergy potentiates immunotherapy in bladder cancer. | Colloids Surf B Biointerfaces | 2025 | 40706095 | PubTator, text mining | PubMed |
| Identification and experimental validation of Alzheimer's disease hub genes via bioinformatics and machine learning. | J Alzheimers Dis Rep | 2025 | 40678591 | PubTator, text mining | PubMed |
| Hypoxia, cuproptosis, and osteoarthritis: Unraveling the molecular crosstalk. | Redox Biol | 2025 | 40669206 | PubTator, text mining | PubMed |
| Mesoporous Nanoplatform That Efficiently Delivers DOX as an H2O2 Generator to Trigger Mutual Amplification of Cuproptosis and Chemodynamic Therapy. | Adv Healthc Mater | 2025 | 40653931 | PubTator, text mining | PubMed |
| Human cytomegalovirus protein UL13 targets to mitochondria to induce cuproptosis. | Biochem Biophys Res Commun | 2025 | 40652815 | PubTator, text mining | PubMed |
| Personal Values for Sustainable Eating: A Preliminary Investigation of a Value-Based Planned Behavior Model. | Nutrients | 2025 | 40647328 | PubTator, text mining | PubMed |
| Tanshinone IIA induces oxidative stress in trophoblast cells and enhances copper dependent death. | Sci Rep | 2025 | 40646006 | PubTator, text mining | PubMed |
| Configuration analysis of crop-pollination service management: a novel insight from the theory of planned behavior. | PLoS One | 2025 | 40644515 | PubTator, text mining | PubMed |
| Modulating ovarian cancer progression through FDX1-driven autophagy. | NPJ Precis Oncol | 2025 | 40629130 | PubTator, text mining | PubMed |
| The potential role of cuproptosis-related genes for therapy and immunoregulation in pan-cancer. | PLoS One | 2025 | 40601654 | PubTator, text mining | PubMed |
| Analysing fast food consumption behaviour patterns: The case of Jordan. | PLoS One | 2025 | 40577369 | PubTator, text mining | PubMed |
| Improving Parent-Adolescent Conversation to Promote Adolescent Sleep Health Behavior Change: An Open Trial of the Parent Behavior Change Intervention. | Behav Ther | 2025 | 40541373 | PubTator, text mining | PubMed |
| In silico development and validation of a novel six-gene-derived signature in hepatocellular carcinoma. | Transl Cancer Res | 2025 | 40530125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=12